Pulmatrix (PULM) Non-Current Debt (2015 - 2017)
Pulmatrix (PULM) posted Non-Current Debt of $1.8 million for Q2 2017, down 28.47% sequentially from $2.5 million in Q1 2017, and down 60.33% YoY from $4.5 million in Q2 2016.
Pulmatrix (PULM) Non-Current Debt (2015 - 2017) Analysis & Trends
Pulmatrix has reported Non-Current Debt for 3 years, with the latest figure at $1.8 million in Q2 2017.
- Quarterly Non-Current Debt fell 60.33% year-over-year to $1.8 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.8 million (down 60.33% YoY) and the FY2016 annual result came in at $3.2 million, down 43.48% from the prior year.
- Non-Current Debt slipped to $1.8 million in Q2 2017 per PULM's latest filing, from $2.5 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $6.7 million in Q2 2015 and troughed at $1.8 million in Q2 2017.
- A 3-year average of $4.4 million and a median of $4.5 million in 2016 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2016 and 2017: Non-Current Debt tumbled 32.18% in 2016, then tumbled 60.33% in 2017.
- Over 3 years, Non-Current Debt stood at $5.7 million in 2015, then sank by 43.48% to $3.2 million in 2016, then slumped by 43.92% to $1.8 million in 2017.
- According to Business Quant data, Non-Current Debt over the past three periods registered $1.8 million, $2.5 million, and $3.2 million for Q2 2017, Q1 2017, and Q4 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 8.96 Bn |
| 10 | Pulmatrix | 5.62 Mn | 5.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 1.80 Mn |
| Mar 31, 2017 | 2.52 Mn |
| Dec 31, 2016 | 3.22 Mn |
| Sep 30, 2016 | 3.89 Mn |
| Jun 30, 2016 | 4.55 Mn |
| Mar 31, 2016 | 5.07 Mn |
| Dec 31, 2015 | 5.69 Mn |
| Sep 30, 2015 | 6.31 Mn |
| Jun 30, 2015 | 6.71 Mn |